Thermo Fisher Sci…
USUSDThermo Fisher Scientific Inc (LSE:0R0H) — Industrial Machinery/Components. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 3. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.
Apie Įmonę
- Svetainė
- thermofisher.com
- Sektorius
- Industrials · Industrial Machinery/Components
- Būstinė
- Waltham, United States
- Generalinis Direktorius
- Marc N. Casper
- Darbuotojai
- 67 816
- Įkurta
- 2006
- Biržoje Nuo
- 29.01.2018 (LSE:0R0H)
- Apyvartoje Esančios Akcijos
- 369.75 mln. 2026-06-27 duomenimis
- Laisvai Apyvartinės Akcijos
- 368.82 mln.
- Rinkos Kapitalizacija
- 241.26 mlrd. USD
- Insaideriai
- 0.13%
- Instituciniai Investuotojai
- 94.08%
- Šaka (SIC)
- Measuring & Controlling Devices, NEC
- Teisinė Forma
- XTIQ
- ISIN
- US8835561023
- LEI
- HCHV7422L5HDJZCRFL38
- Išmokų Santykis
- 9.5%
- FCF
- 7.32 mlrd. USD
- Payout / FCF
- 9%
- Skola
- 42.3 mlrd. USD5.2 m. FCF
- Dividendų Stažas
- 14 m.
- Pelnas, FCF ir dividendai – už 12 mėnesių iki 27.06.2026 (naujausia įmonės ataskaita).
Aprašymas
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Dividendai
Thermo Fisher Scientific Inc (TMO) moka dividendus kas ketvirtį. Per metus (12 mėnesių iki ir įskaitant naujausią paskelbtą mokėjimą): 1.84 USD už akciją (mokėjimai: 4). Tai sudaro apie 0.28% dabartinės akcijų kainos. Pagal išmokų istoriją kita ex-dividendų data tikėtina apie 15.12.2026. Nepertraukiamų dividendų metai: 14.
| Ex Data | Išmoka | Suma | % | Tipas | Tikeris |
|---|---|---|---|---|---|
| 2026-09-15 | 2026-10-15 | 0.4700 USD | 0.1/0.3 % | kas ketvirtį | US:TMO |
| 2026-06-15 | 2026-07-15 | 0.4700 USD | 0.1/0.4 % | kas ketvirtį | US:TMO |
| 2026-03-13 | 2026-04-15 | 0.4700 USD | 0.1/0.4 % | kas ketvirtį | US:TMO |
| 2025-12-15 | 2026-01-15 | 0.4300 USD | 0.1/0.3 % | kas ketvirtį | US:TMO |
| 2025-09-15 | 2025-10-15 | 0.4300 USD | 0.1/0.4 % | kas ketvirtį | US:TMO |
| 2025-06-13 | 2025-07-15 | 0.4300 USD | 0.1/0.4 % | kas ketvirtį | US:TMO |
| 2025-03-14 | 2025-04-15 | 0.4300 USD | 0.1/0.3 % | kas ketvirtį | US:TMO |
| 2024-12-13 | 2025-01-15 | 0.3900 USD | 0.1/0.3 % | kas ketvirtį | US:TMO |
| 2024-09-13 | 2024-10-15 | 0.3900 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2024-06-14 | 2024-07-15 | 0.3900 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2024-03-14 | 2024-04-15 | 0.3900 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2023-12-14 | 2024-01-16 | 0.3500 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2023-09-14 | 2023-10-13 | 0.3500 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2023-06-14 | 2023-07-14 | 0.3500 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2023-03-14 | 2023-04-14 | 0.3500 USD | 0.1/0.2 % | kas ketvirtį | US:TMO |
| 2022-12-14 | 2023-01-16 | 0.3000 USD | 0.0/0.2 % | kas ketvirtį | US:TMO |
| 2022-09-14 | 2022-10-14 | 0.3000 USD | 0.0/0.2 % | kas ketvirtį | US:TMO |
| 2022-06-14 | 2022-07-15 | 0.3000 USD | 0.0/0.1 % | kas ketvirtį | US:TMO |
| 2022-03-15 | 2022-04-14 | 0.3000 USD | 0.0/0.1 % | kas ketvirtį | US:TMO |
| 2021-12-14 | 2022-01-14 | 0.2600 USD | 0.0/0.0 % | kas ketvirtį | US:TMO |
Didžiausi Akcininkai
| Turėtojas | Dalis | Akcijos | Ataskaitos Data |
|---|---|---|---|
| Blackrock Inc. | 8.36% | 30.92 mln. | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 24.28 mln. | 2026-06-30 |
| State Street Corporation | 4.55% | 16.83 mln. | 2026-06-30 |
| FMR, LLC | 3.81% | 14.08 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.19% | 11.8 mln. | 2026-06-30 |
| Morgan Stanley | 2.91% | 10.76 mln. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 9.63 mln. | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.3% | 8.5 mln. | 2026-06-30 |
| Geode Capital Management… | 2.27% | 8.38 mln. | 2026-06-30 |
| Franklin Resources, Inc. | 1.97% | 7.27 mln. | 2026-06-30 |
| Vanguard Portfolio Manag… | 1.68% | 6.23 mln. | 2026-06-30 |
| Capital World Investors | 1.68% | 6.2 mln. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 4.95 mln. | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 4.81 mln. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 4.55 mln. | 2026-08-31 |
| Fidelity Contrafund | 1.06% | 3.91 mln. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 3.54 mln. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 2.67 mln. | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.56% | 2.06 mln. | 2026-06-30 |
| VANGUARD INSTITUTIONAL I… | 0.55% | 2.02 mln. | 2026-06-30 |
| CASPER MARC N (Chief Exe… | ≈0.04% | 140 225 | 2026-08-24 |
| LAGARDE MICHEL (Chief Op… | ≈0.02% | 86 347 | 2026-02-25 |
| SPERLING SCOTT M (Direct… | ≈0.02% | 69 479 | 2026-05-20 |
| WILLIAMSON STEPHEN (Chie… | ≈0.01% | 46 095 | 2026-02-25 |
| PETTITI GIANLUCA (Presid… | ≈0.01% | 23 216 | 2026-08-31 |
| SHAFER MICHAEL D (Office… | ≈0.01% | 20 994 | 2026-08-11 |
| LOWERY FREDERICK M. (Off… | ≈0% | 17 133 | 2026-02-25 |
| CHAI NELSON J (Director) | ≈0% | 15 316 | 2026-05-20 |
| BRITT LISA P (Officer) | ≈0% | 14 784 | 2026-08-19 |
| BOXER MICHAEL A (General… | ≈0% | 10 815 | 2025-03-10 |
